Julie is mutivated by products that tangibly improve patients lives. She invests in early stage biopharma and digital health ventures, and leads new company formation efforts as an executive. Julie previously worked at Genentech across development and commercial divisions and also served on the board of the Biden Cancer Initiative and co-chaired Planned Parenthood NorCal's IT Advisory Board. She holds an M.B.A. from Stanford, an MPhil. in BioScience Enterprise from Cambridge and a B.S. in Molecular Biophysics and Biochemistry from Yale.